Except it isn't, Xena. CU patients were up to 46 weeks. Except current SOC is barely any good and even worse after 10 weeks so that's all that has to be beaten anyway. Batteries have nothing to do with any of this. Research shows that synapses can be repaired and regrown and protected under normal enzymatic circumstances. Why would that be like a jump started battery? If it jump starts, it seems to be a pretty strong start with no sign of slowing down. https://i.imgur.com/579PX0L.jpg You are certainly entitled to your opinion but I don't see how its based on science. I'll 100% admit any of these stocks are risky, because AD is hard to get a handle on. It seems that most are willing to admit that synaptic damage plays a role, yet won't consider a drug that can repair the synapses as a potential avenue.
News 
Market Data 
Discover 
AI
